UBS Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Delivering The Goods
Tweet Send to a FriendGet Alerts TMO Hot Sheet
Price: $86.27 +0.90%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade TMO Now!
UBS maintains a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target raised from $62 to $64.
Analyst, Daniel Arias, said, "Q1 revs of $3,100M (+14% y/y) beat Street $2,977, as TMO recorded above consensus sales growth of 4% (UBSe 4%). Gross margins were up 180 bps, while adjusted operating margins improved 90 bps to 18.5% (UBSe 18.8%) on productivity gains, cost savings, M&A accretion, & volume. Adjusted EPS beat of $1.17 vs. UBSe $1.14 & Street $1.11. We think 1Q results highlighted Thermo’s relative stability & diversity, which represent key attributes going fwd. TMO remains one of our top picks – particularly in light of a 25% valuation discount to the group on fwd P/E."
"We see ’12-13 sales of $12,491M (+6.5%, 3.8% org) & $12,860M (+3%), w/ EPS of $4.82 (was $4.81) & $5.40 (was $5.34), respectively."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $55.07 yesterday, with a 52 week range of $43.06-$65.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Daniel Arias, said, "Q1 revs of $3,100M (+14% y/y) beat Street $2,977, as TMO recorded above consensus sales growth of 4% (UBSe 4%). Gross margins were up 180 bps, while adjusted operating margins improved 90 bps to 18.5% (UBSe 18.8%) on productivity gains, cost savings, M&A accretion, & volume. Adjusted EPS beat of $1.17 vs. UBSe $1.14 & Street $1.11. We think 1Q results highlighted Thermo’s relative stability & diversity, which represent key attributes going fwd. TMO remains one of our top picks – particularly in light of a 25% valuation discount to the group on fwd P/E."
"We see ’12-13 sales of $12,491M (+6.5%, 3.8% org) & $12,860M (+3%), w/ EPS of $4.82 (was $4.81) & $5.40 (was $5.34), respectively."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $55.07 yesterday, with a 52 week range of $43.06-$65.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Deutsche Bank Raises PT on Access Midstream Partners (ACMP) to $57
- UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
